Peanut Allergy Pipeline Report, 2023 Updates: In-depth Analysis into the Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Emerging Drugs, and Growth Prospects | Vedanta Biosciences, Inc., Allergy Therapeutics, COUR Pharmaceutical Development Company,

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Peanut Allergy pipeline constitutes 15+ key companies continuously working towards developing 15+ Peanut Allergy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Peanut Allergy Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Peanut Allergy Market.

The Peanut Allergy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Peanut Allergy Pipeline Report: https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Peanut Allergy treatment therapies with a considerable amount of success over the years.
• Peanut Allergy companies working in the treatment market are Allergy Therapeutics, Intrommune Therapeutics, InnoUp Farma, Cour Pharmaceutical, Vedanta Biosciences, Aravax, Prota Therapeutics, AstraZeneca, DBV technologies, Camallergy, Genentech, ALK-Abelló A/S/Syneos Health, DBV Technologies, Aimmune Therapeutics, Inc., Novartis, Alladapt Immunotherapeutics, Inc., and others, are developing therapies for the Peanut Allergy treatment
• Emerging Peanut Allergy therapies in the different phases of clinical trials are- VLP Peanut, INT301, INP20, CNP-201, VE416, PVX-108, PRT100, Acalabrutini, Viaskin Peanut, CA002, Omalizumab, Peanut SLIT-tablet, DBV712, AR101, Ligelizumab, Remibrutinib, ADP101, and others are expected to have a significant impact on the Peanut Allergy market in the coming years.
• In December 2023, The primary objective of this current inquiry is to outline recent clinical trials, dosage mechanisms, and the practical application of Palforzia, the initial oral immunotherapy introduced for individuals with peanut allergy. Palforzia represents a new approach in managing allergic responses in patients who previously had refractory immune modulation or underwent immune environment sensitivity testing, allowing for more targeted treatment. Ongoing research is concentrating on specific age brackets demonstrating greater responsiveness to this treatment method.
• In September 2022, The US Food and Drug Administration (FDA) has placed a partial clinical hold on the phase III VITESSE (Viaskin Peanut Immunotherapy Trial to Evaluate Safety, Simplicity and Efficacy) trial. This trial evaluates the safety and effectiveness of epicutaneous immunotherapy utilizing the modified Viaskin Peanut 250 µg patch in children aged 4-7 years.
• In June 2022, DBV Technologies released favorable top-line findings from the Phase III EPITOPE Trial evaluating Viaskin Peanut in peanut-allergic toddlers. The safety outcomes from EPITOPE were largely in line with the safety record of Viaskin Peanut 250 μg previously observed in clinical trials involving children aged 4 years and older with peanut allergy.
• In June 2022, DBV Technologies unveiled encouraging top-line outcomes from the Phase III EPITOPE Trial investigating Viaskin Peanut in toddlers afflicted with peanut allergies. The safety characteristics exhibited by Viaskin Peanut 250 μg, as previously observed in clinical trials involving children aged 4 and above with peanut allergy, were broadly consistent with the safety data reported in the EPITOPE Trial.

Peanut Allergy Overview
The majority of severe food-related allergic responses are caused by peanut allergies. It usually manifests early in childhood, and those who are affected rarely outgrow it. Traces of an allergen can cause an allergic reaction in highly sensitized individuals. Ara h1, h2, and h 3 are the main peanut antigens that have been identified by the particular antibody response.

Get a Free Sample PDF Report to know more about Peanut Allergy Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Peanut Allergy Drugs Under Different Phases of Clinical Development Include:
• VLP Peanut: Allergy Therapeutics
• INT301: Intrommune Therapeutics
• INP20: InnoUp Farma
• CNP-201: Cour Pharmaceutical
• VE416: Vedanta Biosciences
• PVX-108: Aravax
• PRT100: Prota Therapeutics
• Acalabrutinib: AstraZeneca
• Viaskin Peanut: DBV technologies
• CA002: Camallergy
• Omalizumab: Genentech
• Peanut SLIT-tablet: ALK-Abelló A/S/Syneos Health
• DBV712: DBV Technologies
• AR101: Aimmune Therapeutics, Inc.
• Ligelizumab: Novartis
• Remibrutinib: Novartis
• ADP101: Alladapt Immunotherapeutics, Inc.

Peanut Allergy Route of Administration
Peanut Allergy pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intradermal
• Intravenous
• Subcutaneous
• Topical.
• Molecule Type
Peanut Allergy Molecule Type
Peanut Allergy Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type

Peanut Allergy Pipeline Therapeutics Assessment
• Peanut Allergy Assessment by Product Type
• Peanut Allergy By Stage and Product Type
• Peanut Allergy Assessment by Route of Administration
• Peanut Allergy By Stage and Route of Administration
• Peanut Allergy Assessment by Molecule Type
• Peanut Allergy by Stage and Molecule Type
DelveInsight's Peanut Allergy Report covers around 15+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Peanut Allergy product details are provided in the report. Download the Peanut Allergy pipeline report to learn more about the emerging Peanut Allergy therapies
https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Peanut Allergy Therapeutics Market include:
Key companies developing therapies for Peanut Allergy are - Vedanta Biosciences, Inc., Allergy Therapeutics, COUR Pharmaceutical Development Company, Inc., ALK-Abelló A/S, Syneos Health, DBV Technologies, Aimmune Therapeutics, Inc., Novartis Pharmaceuticals, National Institute of Allergy and Infectious Diseases (NIAID), Alladapt Immunotherapeutics, Inc., and others.

Peanut Allergy Pipeline Analysis:
The Peanut Allergy pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Peanut Allergy with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Peanut Allergy Treatment.
• Peanut Allergy key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Peanut Allergy Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Peanut Allergy market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Peanut Allergy drugs and therapies
https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Peanut Allergy Pipeline Market Drivers
• Increasing prevalence of peanut allergies, growth in commercial and scientific activities for research and development are some of the important factors that are fueling the Peanut Allergy Market.

Peanut Allergy Pipeline Market Barriers
• However, lack of approved therapies, lack of public awareness of peanut allergy, accurate diagnosis of peanut allergy is critical and other factors are creating obstacles in the Peanut Allergy Market growth.

Scope of Peanut Allergy Pipeline Drug Insight
• Coverage: Global
• Key Peanut Allergy Companies: Allergy Therapeutics, Intrommune Therapeutics, InnoUp Farma, Cour Pharmaceutical, Vedanta Biosciences, Aravax, Prota Therapeutics, AstraZeneca, DBV technologies, Camallergy, Genentech, ALK-Abelló A/S/Syneos Health, DBV Technologies, Aimmune Therapeutics, Inc., Novartis, Alladapt Immunotherapeutics, Inc., and others
• Key Peanut Allergy Therapies: VLP Peanut, INT301, INP20, CNP-201, VE416, PVX-108, PRT100, Acalabrutini, Viaskin Peanut, CA002, Omalizumab, Peanut SLIT-tablet, DBV712, AR101, Ligelizumab, Remibrutinib, ADP101, and others
• Peanut Allergy Therapeutic Assessment: Peanut Allergy current marketed and Peanut Allergy emerging therapies
• Peanut Allergy Market Dynamics: Peanut Allergy market drivers and Peanut Allergy market barriers

Request for Sample PDF Report for Peanut Allergy Pipeline Assessment and clinical trials
https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Peanut Allergy Report Introduction
2. Peanut Allergy Executive Summary
3. Peanut Allergy Overview
4. Peanut Allergy- Analytical Perspective In-depth Commercial Assessment
5. Peanut Allergy Pipeline Therapeutics
6. Peanut Allergy Late Stage Products (Phase II/III)
7. Peanut Allergy Mid Stage Products (Phase II)
8. Peanut Allergy Early Stage Products (Phase I)
9. Peanut Allergy Preclinical Stage Products
10. Peanut Allergy Therapeutics Assessment
11. Peanut Allergy Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Peanut Allergy Key Companies
14. Peanut Allergy Key Products
15. Peanut Allergy Unmet Needs
16 . Peanut Allergy Market Drivers and Barriers
17. Peanut Allergy Future Perspectives and Conclusion
18. Peanut Allergy Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Peanut Allergy Market https://www.delveinsight.com/report-store/peanut-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Peanut Allergy Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Peanut Allergy Epidemiology https://www.delveinsight.com/report-store/peanut-allergy-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Peanut Allergy Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market
Ventricular Assist Devices Market By Product Type (Left Ventricular Assist Devices, Right Ventricular Assist Devices, And Biventricular Assist Devices), By Application Type (Bridge-To-Transplant [Btt], Destination Therapy, And Others), By Design Type (Transcutaneous Ventricular Assist Devcies And Implantable Ventricular Assist Devices), By Type Of Flow (Pulsatile Flow And Continous Flow), By End User (Hospital And Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of heart failure and cardiovascular diseases due to obesity, age, & unhealthy lifestyles and rising demand for organ transplants due to increasing prevalence of chronic ailments such as hypertension, diabetes, and others

B-cell Non-hodgkin Lymphoma Market https://www.delveinsight.com/report-store/b-cell-non-hodgkin-lymphoma-market
DelveInsight's "B-Cell Non-Hodgkin Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the B-Cell Non-Hodgkin Lymphoma, historical and forecasted epidemiology as well as the B-Cell Non-Hodgkin Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Systemic Sclerosis Market
https://www.delveinsight.com/report-store/systemic-sclerosis-market
DelveInsight's "Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Systemic Sclerosis. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Systemic Sclerosis segmented by gender-specific, age-specific, and type-specific cases.

Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
"DelveInsight's 'Resorbable Vascular Scaffolds Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vascular Stents Market
https://www.delveinsight.com/report-store/vascular-stents-market
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.

Symptomatic Partial-thickness Rotator Cuff Tears Market
https://www.delveinsight.com/report-store/symptomatic-partial-thickness-rotator-cuff-tears-market
DelveInsight's "Symptomatic Partial-thickness Rotator Cuff Tears Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Symptomatic Partial-thickness Rotator Cuff Tears, historical and forecasted epidemiology as well as the Symptomatic Partial-thickness Rotator Cuff Tears market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.